WSC
BIOL

Wellington Shields & Co’s Biolase, Inc. BIOL Stock Holding History

Wellington Shields & Co’s Portfolio BIOL Stock Details BIOL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-7
Closed -$6K – 297
2022
Q1 		$6K Buy
7
+3
+75% +$2.77K ﹤0.01% 224
2021
Q4 		$4K Hold
4
– – ﹤0.01% 228
2021
Q3 		$6K Hold
4
– – ﹤0.01% 213
2021
Q2 		$7K Hold
4
– – ﹤0.01% 210
2021
Q1 		$8K Hold
4
– – ﹤0.01% 198
2020
Q4 		$4K Hold
4
– – ﹤0.01% 186
2020
Q3 		$3K Hold
4
– – ﹤0.01% 177
2020
Q2 		$5K Hold
4
– – ﹤0.01% 176
2020
Q1 		$4K Hold
4
– – ﹤0.01% 156
2019
Q4 		$6K Buy
+4
New +$6.15K ﹤0.01% 175

Other funds holding BIOL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Wellington Shields & Co's BIOL Position: Q2 2022 in Review

Wellington Shields & Co sold out of Biolase, Inc. (BIOL) in Q2 2022, closing a stake of 7 shares — an estimated $6K sold.

Wellington Shields & Co first reported a position in BIOL in Q4 2019 and held it in 10 quarters. The position peaked at $8K in Q1 2021. 16 funds tracked by Wall St. Rank hold BIOL as of Q2 2022.

  • Wellington Shields & Co reported no remaining Biolase, Inc. position as of Q2 2022 after selling out during the quarter.
  • Wellington Shields & Co sold 7 Biolase, Inc. shares in Q2 2022, an estimated $6K.
  • Wellington Shields & Co first reported a position in Biolase, Inc. in Q4 2019 and held it in 10 quarters.
  • Wellington Shields & Co's Biolase, Inc. position peaked at $8K in Q1 2021.
  • 16 funds tracked by Wall St. Rank held Biolase, Inc. as of Q2 2022.

Based on Wellington Shields & Co's 13F filing for Q2 2022, filed 12 Aug 2022.